Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancerD Santini, G Perrone, B Vincenzi, et al.
European Journal of Histochemistry : EJH|September 16, 2010
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypesG Perrone, S Morini, D Santini, et al.
Science Translational Medicine|May 14, 2010
Metabolic modulation of glioblastoma with dichloroacetateE D Michelakis, G Sutendra, P Dromparis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2008
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerM H Cullen, P Zatloukal, S Sörenson, et al.
Current Oncology (Toronto, Ont.)|February 17, 2015
Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancerS Chia, S Gandhi, A A Joy, et al.
Pharmaceutical Biotechnology|April 1, 2000
Nucleoside transporters of mammalian cellsC E Cass, J D Young, S A Baldwin, et al.
British Journal of Cancer|August 22, 2014
Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapyK S Courneya, D C McKenzie, J R Mackey, et al.
Pageof 7